Medical laboratory science is basically applied basic sciences, especially the biological sciences to the study of medicine, particularly the causes, consequences, diagnosis and treatment of human diseases.

It is also referred to as the science of the causes, consequences, diagnosis, treatment and management of disease. The Bachelor of Medical Laboratory Science (BMLS) programme which started recently in this university is actually a resuscitation of the old programme; the Bachelor of Science (B. Sc.) in Medical Laboratory Technology (B. Sc. Med. Lab. Tech.) which was suspended indefinitely in the 1966/ 67 academic sessions (history of the programme at a glance below).

The current programme is consistent with what obtains internationally; incorporating the tremendous advances that have been made in medical sciences in general and the field of laboratory science and medicine in particular. Thus, the new programme is significantly revised to bring in the ever-expanding areas of molecular biology and medicine particularly genomics. This is aimed at producing soundly educated and trained scientifically qualified professionals that can meet the needs of both today's patients as well as the dynamics of health care provision.

History of the BMLS Programme at a Glance

The BSc Medical Laboratory Technology programme started in the 1965/66 Academic session. It was temporarily suspended in the 1967/68 session. The UCH Board of management in 2006 recommended to the Faculty Basic Medical Sciences to reactivate the programme. The curriculum was approved by both the Faculty of Basic Medical Sciences and the Academic Board of the College Approval by Senate, August 2010.

  • NUC Resource verification July 20, 2012
  • NUC Approval for Commencement 27 September, 2012
  • First student in take 2012/2013 session
  • First Head of Department, Professor O.G. Ademowo, 2012-2015


To train biomedical scientists (Medical Laboratory Scientists) with sound scientific background to provide good scientific backbone to the practice of medicine and medical research locally and internationally.

To produce scientists imbued with the central position of ethics in biomedicine and medical practice.

To produce creative medical scientists whose ethos is a lifelong passion for the science that underpins and advances clinical practice and treatment of disease as well as recognizing the concept of team work in science and medicine.


To produce well rounded, creative, visionary, independent minded, and innovative professional biomedical scientists comparable to the best anywhere in the world.


Dr Ishiaq Olayinka OMOTOSHO
Dr Ishiaq Olayinka OMOTOSHO

Dr Ishiaq Olayinka OMOTOSHO was born over 3 decades ago in Ibadan, the capital and most populous city in Nigeria. He had his education in Ibadan from 1964 when he started his primary education till 2007 when he obtained a doctoral degree (PhD) in Biochemical Toxicology from the University of Ibadan. He is a trained Medical Laboratory Scientist licensed by the Medical Laboratory Science Council of Nigeria (MLSCN) of which he is a FELLOW and also as an ASSOCIATE of the Institute of Biomedical Science of the United Kingdom specializing in Chemical Pathology (Clinical Biochemistry).

He has a vast experience as a routine Medical Laboratory Scientist having worked on the bench carrying out various investigations spanning all aspects of clinical biochemistry for more than 2 decades in University College Hospital and later in the College of Medicine of the University of Ibadan. He later joined academics fully as Lecturer I in the Department of Chemical Pathology of the College from he rose to become a Senior Lecturer in 2015.

Dr Omotosho’s research interest covers organ toxicity of lead (Pb) where he worked on developing early markers of toxicity of this metal in various organs of humans. He has extended this to investigating the possible effect of Pb and other metals on the aetiopathogenesis of diseases like glaucoma, cataract, hypertension, chronic kidney diseases and infertility. He has developed a hypothesis on the possible application of “Area under the curve” as early diagnostic tool of kidney failure especially in vulnerable groups of people. He has also investigated possible bioindicators of neurotoxicity to aid the management of neurodevelopmental and neurodegenerative diseases. He has ventured into translational research by looking at the composition and scientific application of some popular herbal preparations where he has identified and established in-vivo cytotoxic effect of fraction of this preparation as cytotoxic drug in cervical cell line in experimental animal. Dr Omotosho is happily married with grandchildren.